Burdett, Nikki L.
Willis, Madelynne O. http://orcid.org/0000-0002-5387-6255
Alsop, Kathryn
Hunt, Allison L. http://orcid.org/0000-0002-2223-7944
Pandey, Ahwan http://orcid.org/0000-0003-2238-1054
Hamilton, Phineas T.
Abulez, Tamara http://orcid.org/0000-0001-5325-5064
Liu, Xuan
Hoang, Therese
Craig, Stuart
Fereday, Sian http://orcid.org/0000-0002-8559-8579
Hendley, Joy
Garsed, Dale W. http://orcid.org/0000-0003-1223-0121
Milne, Katy http://orcid.org/0000-0001-5616-1821
Kalaria, Shreena
Marshall, Ashley
Hood, Brian L.
Wilson, Katlin N.
Conrads, Kelly A.
Pishas, Kathleen I.
Ananda, Sumitra
Scott, Clare L. http://orcid.org/0000-0002-3689-5956
Antill, Yoland
McNally, Orla
Mileshkin, Linda http://orcid.org/0000-0001-6826-6014
Hamilton, Anne http://orcid.org/0000-0003-0368-9838
Au-Yeung, George
Devereux, Lisa http://orcid.org/0000-0003-2435-5888
Thorne, Heather
Bild, Andrea http://orcid.org/0000-0002-4727-5533
Bateman, Nicholas W. http://orcid.org/0000-0002-4425-9511
Maxwell, G. Larry
Chang, Jeffrey T. http://orcid.org/0000-0002-4578-5636
Conrads, Thomas P. http://orcid.org/0000-0003-4742-3281
Nelson, Brad H. http://orcid.org/0000-0002-4445-5539
Bowtell, David D. L.
Christie, Elizabeth L. http://orcid.org/0000-0002-9959-7024
Article History
Received: 22 November 2021
Accepted: 26 January 2023
First Online: 27 February 2023
Competing interests
: T.P.C. is a ThermoFisher Scientific, Inc. SAB member and receives research funding from AbbVie. G.A.-Y. receives institutional grant funding from AstraZeneca and Roche-Genentech for unrelated work. AOCS (D.D.L.B., K.A., S.F. and J.H.) has received grant funding from AstraZeneca for an unrelated study. C.L.S. receives grant or research support from AstraZeneca, Clovis Oncology, Eisai, Inc., Sierra Oncology, Roche and Beigene for unrelated work, and sits on advisory boards for AstraZeneca, Clovis Oncology, Eisai, Inc., Sierra Oncology, Roche, Takeda and MSD. The remaining authors declare no competing interests.